Miami Beach, FL, United States of America

Joshua Hare

This inventor holds 21 USPTO granted patents and 28 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Cardiac Stem Cells. Top assignees: University of Miami, Vestion, Inc., Duke University. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joshua Hare. Retrieved from https://idiyas.com/inventor/joshua-hare

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 28)

% Patents Active = 81.0

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 9 (Patent Applications = 17)

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 109(Granted Patents)

Location History:

Baltimore, MD (US) (2006 - 2011)
Miami Beach, FL (US) (2013 - 2023)
Miami, FL (US) (2024)

Company Filing History:

The United States Government as Represented by the Department of Veterans Affairs

patents

6. 2 out of 3,801

Johns Hopkins University

patents

7. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Cardiac Stem Cells

Mesenchymal Stem Cells

Ischemic Disorders

Biomarkers

Gene Expression Profile

Vaccine Adjuvants

Cell Therapy

Aging Frailty

Inflammatory Cardiomyopathy

GHRH Agonists

Therapeutic Methods

Cardioprotective Effects

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12540357 - Method of determining responsiveness to cell therapy in dilated cardiomyopathy (2026-02-03),

2. 12496316 - Treatment of sexual dysfunction and improvement in sexual quality of life (2025-12-16),

3. 12465620 - Method of treating aging frailty in subjects with inflammaging using human mesenchymal stem cells (2025-11-11),

4. 12168028 - Methods for obtaining cardiomyogenic precursor cells (2024-12-17),

5. 11975068 - Mesenchymal stem cells as vaccine adjuvants and methods for using the same (2024-05-07),

6. 11591655 - Diagnostic transcriptomic biomarkers in inflammatory cardiomyopathies (2023-02-28),

7. 10874698 - Therapy using cardiac stem cells and mesenchymal stem cells (2020-12-29),

8. 10786536 - Cardiac neural crest cells and methods of use thereof (2020-09-29),

9. 10709742 - Method to amplify cardiac stem cells in vitro and in vivo (2020-07-14),

10. 10555987 - GHRH agonists for the treatment of ischemic disorders (2020-02-11),

11. 10481147 - Cardiac stem cells and methods of identifying and using the same (2019-11-19),

12. 10131948 - Transcriptomic biomarkers for individual risk assessment in new onset heart failure (2018-11-20),

13. 9980985 - Pharmaceutical coposition of cardiac stem cells and mesenchymal stem cells (2018-05-29),

14. 9962409 - Therapy using cardiac stem cells and mesenchymal stem cells (2018-05-08),

15. 9855312 - GHRH agonists for the treatment of ischemic disorders (2018-01-02),

Title: Joshua Hare: Pioneering Innovations in Miami Beach

Introduction:

Joshua Hare, a passionate inventor based in Miami Beach, FL, is a true pioneer in the field of innovation. With a relentless drive to improve the world through his inventions, he has left a lasting impact on the industry and beyond.

Latest Patents:

1. Diagnostic transcriptomic biomarkers in inflammatory cardiomyopathies: Joshua Hare's innovative work has led to the identification of molecular signatures that serve as highly sensitive diagnostic biomarkers for myocarditis, heart disease, and related disorders.

2. Therapy using cardiac stem cells and mesenchymal stem cells: Hare's breakthrough compositions involve delivering stem cells into infarcted myocardium by endocardial injection. These stem cells engraft and differentiate into various crucial cells without the need for survival-enhancing modification. They have shown efficiency in engrafting both acutely and late after myocardial infarction.

Career Highlights:

Throughout his career, Joshua Hare has contributed significantly to the field of innovation. He has held positions at Vestion, Inc., and the University of Miami, where he has showcased his exceptional talent and dedication to advancing medical technologies.

Collaborations:

Joshua Hare has collaborated with esteemed professionals in the industry, including Konstantinos Chatzistergos and Alan W Heldman. Together, they have worked on cutting-edge projects that have pushed the boundaries of scientific discovery and medical advancements.

Conclusion:

In conclusion, Joshua Hare's unwavering commitment to innovation and his groundbreaking inventions have solidified his place as a visionary in the field. His work continues to inspire future generations of inventors and researchers to strive for excellence in creating technologies that have a positive impact on society.

Profile summary based on public USPTO records.